Correction: MALAT1 is Associated with Poor Response to Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2 Free

In the original version of this article (1), wrong images were used in Fig. 2F (invasion of si-NC–transfected HT29OxR cells), Fig. 4C (migration of HT29 cells), and Fig. 5G (si-EZH2–transfected SW620 cells). The error occurred when the authors arranged the images for these figures. The authors regret this error.